I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

*M*enopause is the permanent cessation of menstruation due to the loss of ovarian function which occurs at a mean age of 50 years.\[[@ref1]\]

The ovaries no longer secrete progesterone and estrogen in appreciable quantities. The transition from premenopause to postmenopause is associated with many features of metabolic syndrome.\[[@ref2]\]

The emergence of risk factors may be a direct result of ovarian failure or an indirect result of metabolic consequences or central fat redistribution with estrogen deficiency.\[[@ref3]\]

The hormonal changes associated with menopause, that is, low plasma levels of estrogen and marked increase in follicle-stimulating hormone and luteinizing hormone exert a significant effect on plasma lipids and lipoproteins leading to increase in low-density lipoprotein (LDL) cholesterol and decrease in high-density lipoprotein (HDL) cholesterol, henceforth, leading to increased risk of cardiovascular disease in postmenopausal women.\[[@ref4]\]

Decreased level of estrogen in postmenopausal women causes alteration in cardiac autonomic system leading to a decrease in vagal tonic modulation of the heart rate in the setting of preserved sympathetic tone and consequently there is predominance of sympathetic tone leading to decreased heart rate variability further predisposing to cardiovascular disease in the postmenopausal women.\[[@ref4][@ref5][@ref6]\]

Various research evidences suggest that cardiovascular autonomic balances are related to baroreceptor sensitivity and heart rate variability. It has been observed that in women, oophorectomy suppresses baroreceptor sensitivity and heart rate variability.\[[@ref3]\] It has also been demonstrated that estrogen supplementation increases baroreceptor sensitivity and heart rate variability.\[[@ref3]\]

Various studies suggested beneficial effect of estrogen replacement therapy would reduce the relative risk for cardiovascular mortality, due to actions of estrogen on improving serum cholesterol profile by decreasing total cholesterol (TC) and LDL cholesterol and increasing HDL cholesterol. Estrogen was considered beneficial by relaxing smooth muscles, endothelium-dependent vasodilation formation, and decreasing fibrinogen levels causing favorable impact on clotting mechanism along with direct inotropic effect on heart.\[[@ref6]\]

During postmenopausal period, due to hormonal imbalance, a myriad of vague symptoms centered around vasomotor symptoms arise such as hot flushes and sweating, and emotional symptoms such as depression and anxiety may occur in symptomatic postmenopausal women.\[[@ref6]\]

Various studies have shown that in healthy postmenopausal women, dyslipidemia is associated with heart rate variability, as a result of decreased level of estrogen.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

Materials {#sec2-1}
---------

The present study titled "study of clinical and biochemical parameters with reference to autonomic dysfunction and dyslipidemia in healthy postmenopausal women" was carried out on sixty healthy postmenopausal women before the age of 65 years, in medicine wards of Padmashree Dr. D. Y. Patil Hospital from July 2012 to July 2014. The Institute Ethics Committee clearance will be obtained before the start of study. All patients will be explained about the nature of the study and informed consent will be obtained from all the patients.

Inclusion criteria {#sec2-2}
------------------

All healthy postmenopausal women who have attained menopause by natural means before the age of 65 years.

Exclusion criteria {#sec2-3}
------------------

Postmenopausal women with:

Diabetes mellitusHypertensionObesityUnderwent hysterectomy/oophorectomyOn hormone replacement therapyOn lipid-lowering drugsHistory of hormonal imbalance or hormonal disorder.

Methods and study plan {#sec2-4}
----------------------

A total number of sixty postmenopausal women admitted in medicine wards of Dr. D. Y. Patil Hospital and Research Centre, Pimpri, Pune, were evaluated by taking a detailed clinical history and clinical examination.

Clinical examination was done:

Weight in Kg/height in meters taken to calculate body mass index (kg/m^2^)Measuring waist--hip ratioDetailed neurological examination was done to detect autonomic dysfunction by five standard bedside cardiovascular tests.

The five autonomic dysfunction tests were explained in detail in the review of literature of this present study.

Heart rate response to Valsalva maneuver - The Valsalva ratio, that is, the ratio of longest R R interval after 20 beats of end of maneuver to the shortest R R interval during the maneuver was calculated. The result was taken as three successive readings. A ratio of 1.1 or lower was taken abnormal\[[@ref7][@ref8][@ref9][@ref10]\] \[[Figure 1](#F1){ref-type="fig"}\]Heart rate response to Valsalva maneuver - The Valsalva ratio, that is, the ratio of longest R-R interval after 20 beats of end of maneuver to the shortest R-R interval during the maneuver was calculated. The result was taken as three successive readings. A ratio of 1.1 or lower was taken abnormal\[[@ref7][@ref8][@ref9][@ref10]\]Heart rate response to standing up from supine position -- The ratio of longest R-R interval around 30^th^ beat after standing. To the shortest R-R interval, around 15^th^ beat after standing was calculated. A ratio \<1 was taken as abnormal\[[@ref7][@ref8][@ref9][@ref10]\]Blood pressure response to sustained handgrip -- A \<10 mmHg increase in diastolic pressure before and 3 min after sustained handgrip was taken as abnormal\[[@ref7][@ref8][@ref9][@ref10]\]Blood pressure response to standing up from supine position - It was measured while the participant was lying supine and again 1 min after standing up and the difference was noted. In normal participant, the systolic blood pressure should not decrease by more than 10 mmHg, in patients with autonomic dysfunction, the systolic blood pressure falls more than 30 mmHg\[[@ref7][@ref8][@ref9][@ref10]\] \[[Figure 2](#F2){ref-type="fig"}\].

![Heartrate response to valsalva maneuver being done on a patient](JMH-8-103-g001){#F1}

![Blood pressure response to standing up from supine position](JMH-8-103-g002){#F2}

Autonomic dysfunction when present will be classified using criteria of Ewing and Clarke as follows:

Normal: All five tests normalEarly involvement: One of the three heart rate tests abnormalDefinite involvement: Two or more of the heart rate tests abnormalSevere involvement: Two or more of the heart rate tests abnormal plus one or both of the blood pressure tests abnormalAtypical pattern: Any other combination of abnormal tests.

Investigations {#sec2-5}
--------------

All patients who fulfilled inclusion criteria underwent investigations. Blood was withdrawn from all patients for hemoglobin, fasting lipid profile, and fasting blood sugar. All patients underwent ECG to look for evidence of ischemic heart disease.

Fasting lipid profile {#sec2-6}
---------------------

A volume of 10 ml of blood after 12 h of fasting was collected for the analysis of lipid profile. The analysis was performed on autoanalyzer ERBA SmartLab ERBA test kit REKT104 for TC, REKT40 for triglycerides (TGLs), and REKT106 for HDL, LDL cholesterol was calculated using the Freidewald formula:

LDL cholesterol = TC − HDL cholesterol − TGLs/5.

The levels of the individual fractions of the lipid profile were interpreted as follows, in accordance with the National Cholesterol Education Program guidelines\[[@ref11]\] \[[Table A](#TA){ref-type="table"}\].

###### 

The levels of the individual fractions of the lipid profile as per NCEP

![](JMH-8-103-g003)

###### 

Autonomic dysfunction wise distribution of cases in study group

![](JMH-8-103-g004)

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Of the sixty healthy postmenopausal women included in the study group, 67% had autonomic dysfunction and 33% did not have autonomic dysfunction. This distribution is seen in the pie diagram \[[Figure 3](#F3){ref-type="fig"} and [Table 1](#T1){ref-type="table"}\].

![Pie diagram showing Autonomic dysfunction-wise distribution of cases in study group](JMH-8-103-g005){#F3}

###### 

Dyslipidemia-wise distribution of cases in study group

![](JMH-8-103-g006)

Of the sixty healthy postmenopausal women included in the study, 68% had dyslipidemia and 33% did not have dyslipidemia. This distribution is seen in the pie diagram \[[Figure 4](#F4){ref-type="fig"} and [Table 2](#T2){ref-type="table"}\].

![Pie diagram showing dyslipidemia-wise distribution of cases in study group](JMH-8-103-g007){#F4}

###### 

Association between dyslipidemia and autonomic dysfunction in study group

![](JMH-8-103-g008)

Out of sixty healthy postmenopausal women, 41 patients have dyslipidemia -- out of which 40 patients have autonomic dysfunction. The *P* \< 0.0001 is statistically significant hence proving a strong correlation between dyslipidemia and autonomic dysfunction in healthy postmenopausal women. This distribution is seen in the bar diagram \[[Figure 5](#F5){ref-type="fig"} and [Table 3](#T3){ref-type="table"}\].

![Bar diagram showing association between autonomic dysfunction and dyslipidemia in study group](JMH-8-103-g009){#F5}

###### 

Comparison of serum cholesterol according to autonomic dysfunction in study group

![](JMH-8-103-g010)

In this study, the cutoff value for normal TC is taken as dysfunction, *P* \< 0.0001 which is statistically significant. Hence, the correlation of autonomic dysfunction and serum cholesterol level in healthy postmenopausal women is proved \[[Figure 6](#F6){ref-type="fig"} and [Table 4](#T4){ref-type="table"}\].

![Bar diagram showing comparision of serum cholesterol according to autonomic dysfunction in study group](JMH-8-103-g011){#F6}

###### 

Comparison of serum triglyceride according to autonomic dysfunction in study group

![](JMH-8-103-g012)

In this study, the cutoff value for normal TGL is taken as \< 0.0001 which is statistically significant. Hence, the correlation of autonomic dysfunction and serum TGL level in healthy postmenopausal women is proved \[[Figure 7](#F7){ref-type="fig"} and [Table 5](#T5){ref-type="table"}\].

![Bar diagram showing comparision of serum triglycerides according to autonomic dysfunction in study group](JMH-8-103-g013){#F7}

###### 

Comparison of serum low.density lipoprotein according to autonomic dysfunction in study group

![](JMH-8-103-g014)

In this study, the cutoff value for normal TC is taken as \< 0.0001 which is statistically significant. Hence, the correlation of autonomic dysfunction and serum LDL level in healthy postmenopausal women is proved \[[Figure 8](#F8){ref-type="fig"} and [Table 6](#T6){ref-type="table"}\].

![Bar diagram showing comparision of serum LDL-Cholesterol according to autonomic dysfunction in study group](JMH-8-103-g015){#F8}

###### 

Comparison of serum high-density lipoprotein according to autonomic dysfunction in study group

![](JMH-8-103-g016)

In this study, the cutoff value for normal TC is taken as 0.05 which is not statistically significant \[[Figure 9](#F9){ref-type="fig"} and [Table 7](#T7){ref-type="table"}\].

![Bar diagram showing comparision of serum HDL-Cholesterol according to autonomic dysfunction in study group](JMH-8-103-g017){#F9}

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Our study was carried out in sixty healthy postmenopausal women fulfilling inclusion criteria in Dr. D. Y. Patil Hospital and Research Centre, Pimpri, Pune, from July 2012 to August 2014.

In our study, the largest group was in the age range of 55--60 years (50%) and the females of age range of 50--55 years is 20% and females of age range of 60--65 years is 30%.

In this study, most of the cases have the normal body mass index and normal waist--hip ratio and their comparison with autonomic dysfunction is not statistically significant, *P* \> 0.05. However, in the study by Kimura *et al*.,\[[@ref12]\] obese patients had significantly lower autonomic functions as compared to nonobese patients.

Out of sixty healthy postmenopausal women in this study, 41 patients have dyslipidemia -- out of which 40 patients have autonomic dysfunction.

The *P* \< 0.0001 is statistically significant hence proving a strong correlation between autonomic dysfunction and dyslipidemia in healthy postmenopausal women.

Our data correlate well with other studies like Virtanen *et al*. performed autonomic nerves system tests in healthy postmenopausal women, who were both on and off estrogen replacement therapy. Their results showed autonomic nervous function normal for age. However, in their work, the authors did observe a highly sensitive baroreflex and a strong 30 mmHg blood pressure rise in the orthostatic test after administration of estrogen.\[[@ref13]\]

Saeki *et al*. studied the difference in autonomic regulation induced by posture change between postmenopausal and young women. Their results suggested that cardiac parasympathetic tone may be reduced in older persons in comparison with young women.\[[@ref14]\]

In the Framingham Heart Study,\[[@ref15]\] plasma TGL is an independent predictor of coronary artery disease. This study presented with TGL level \>140 mg/dl in postmenopausal age group in 35% of cases.\[[@ref15]\] In the present study, 61% of healthy postmenopausal women included in the study have serum TGL level \<150 mg/dl and on comparison with autonomic dysfunction, *P* \< 0.0001 which is statistically significant. Hence, the correlation of autonomic dysfunction and serum TGL level in healthy postmenopausal women is proved.

Significant changes in LDL cholesterol and TC like this study were also seen in studies of Danev *et al*.\[[@ref16]\] and Doncheva *et al*.,\[[@ref17]\] in which hypercholesterolemia is associated with decreased 24-h heart rate variability, and decreased heart rate variability is a strong predictor of coronary heart disease.

Our study is well correlated with a recent study conducted by Chaudhuri *et al*.\[[@ref18]\] results showed significant changes in values of autonomic dysfunction tests such as heart rate variability on Valsalva maneuver, deep breath test, and 30:15 R-R intervals and in values of TC, TGL, and LDL in postmenopausal women and the findings of the study indicate an association of postmenopausal altered sympathovagal activity with blood lipid concentrations and the postmenopausal women had a significantly reduced vagal index and a higher sympathetic index of heart rate variability which also support the results of study by Rosano *et al*.\[[@ref19]\]

In this study, the cutoff value for normal TC is taken as \<200 mg/dl and on comparison with autonomic dysfunction, *P* \< 0.0001 which is statistically significant. Hence, the correlation of autonomic dysfunction and serum cholesterol level in healthy postmenopausal women is proved.

The cutoff value for normal serum LDL cholesterol in our study is taken as \<130 mg/dl and on comparison with autonomic dysfunction, *P* \< 0.0001 which is statistically significant. Hence, the correlation of autonomic dysfunction and serum LDL level in healthy postmenopausal women is proved. In this study, the cutoff value for normal HDL cholesterol is taken as \<40 mg/dl and on comparison with autonomic dysfunction, *P* \> 0.05 which is not statistically significant.

R[ESULTS AND]{.smallcaps} C[ONCLUSION]{.smallcaps} {#sec1-5}
==================================================

In the present study, autonomic dysfunction is found in 67% of healthy postmenopausal women. The sixty female healthy postmenopausal women included in the study, 68% has dyslipidemia.

In our study, there is statistically significant correlation between autonomic dysfunction and dyslipidemia in healthy postmenopausal womenIn the healthy postmenopausal women with increased serum cholesterol, serum LDL, and serum TGLs, autonomic dysfunction is present which is statistically significantThere is no statistical significance is found on comparison of serum HDL cholesterol with the autonomic dysfunction in healthy postmenopausal women.
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